Skin Diseases Treatment Industry Data Book - Acne, Actinic Keratosis, Atopic Dermatitis, Alopecia Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030

Grand View Research’s skin diseases treatment industry data book is a collection of market sizing & forecasts insights, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, and macro-environmental analyses studies. Within the purview of the database, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research. The following data points will be included in the final product offering in five reports and one sector report overview.

Access the Global Skin Diseases Treatment Industry Data Book, 2023 to 2030, compiled with details like trade data, pricing intelligence, and competitive benchmarking.

Actinic Keratosis Treatment Market Report Highlights

The global Actinic Keratosis Treatment Market size was estimated USD 6.42 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 4.20% from 2023 to 2030.

• Surgery held the largest revenue share of 65.6% in 2022 owing to the rising adoption of cryotherapy surgery in the management of actinic keratosis
• Nucleoside metabolic inhibitors held the largest revenue share of 32.4% in 2022 and is expected to retain its dominance over the forecast period
• Asia Pacific is expected to grow at the fastest CAGR of 5.6% during the forecast period due to factors such as the high prevalence of AK, rapidly evolving healthcare infrastructure, and rising healthcare expenditures by Asia Pacific countries
• North America dominated the market with the largest revenue share of 41.5% in 2022 due to the rising awareness among people about actinic keratosis, availability of robust treatment options, and improvements in healthcare infrastructure

Order your copy of Free Sample of “Skin Diseases Treatment Industry Data Book - Acne, Actinic Keratosis, Atopic Dermatitis, Alopecia Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research

Alopecia Market Report Highlights

The global Alopecia Market size was estimated at USD 8.19 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 8.74% from 2023 to 2030.

• In 2022, the AA segment dominated the alopecia industry with a revenue share of 35.13% and is anticipated to maintain its pole position throughout the forecast period
• The alopecia universalis segment is expected to witness the fastest growth from 2023 to 2030, owing to the impending approval of pipeline products, such as Pfizer’s Ritlecitinib which is in the pre-registration phase, and Bioniz Therapeutics’s BNZ-1 which is in phase 2 clinical trials
• North America dominated the market in 2022, mainly due to the high consumer awareness, technological advancements, high target disease population, and high healthcare spending
• Asia Pacific is expected to grow at the highest CAGR during the forecast period. This can be majorly attributed to the rising target disease population and rising treatment rate for the disease
• A few of the key market players include Janssen Global Services Inc.; Cipla Limited; Merck & Co., Inc.; GlaxoSmithKline plc; Sun Pharmaceuticals Industries Ltd.; Dr. Reddy’s Laboratories Ltd.; Aurobindo Pharma; Viatris Inc.

Go through the table of content of Skin Diseases Treatment Industry Data Book to get a better understanding of the Coverage and Scope of the study

Competitive Landscape

The presence of well-established companies in the skin diseases treatment market makes the entry of smaller players with newer products difficult. Companies are highly focused on R&D to develop and launch novel products that give them a competitive edge. Moreover, bigger players are aiming at acquiring smaller companies with upcoming promising products.

Key players operating in the Skin Diseases Treatment industry are:

• Novartis AG
• AbbVie, Inc.
• Amgen Inc.
• Johnson & Johnson Services Inc.
• Leo Pharma A/S.

Check out more Industry Data Books, published by Grand View Research

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com/sector-reports-list
Follow Us: LinkedIn | Twitter